Cent European J Urol. 2014;67(3):282-6. doi: 10.5173/ceju.2014.03.art14. Epub 2014 Aug 18.
The evaluation of tissue mass loss in the incision line of prostate with benign hyperplasia performed using holmium laser and cutting electrode.
Central European journal of urology
Mariusz Szewczyk, Dorota Jesionek-Kupnicka, Marek Ireneusz Lipiński, Piotr Lipinski, Waldemar Różański
Affiliations
Affiliations
- 2 Clinic of Urology, Medical University of ?ód?, Poland.
- Pathology Unit and Department of Oncology, Medical University of ?ód?, Poland.
PMID: 25247088
PMCID: PMC4165671 DOI: 10.5173/ceju.2014.03.art14
Abstract
INTRODUCTION: The aim of this study is to compare the changes in the incision line of prostatic adenoma using a monopolar cutting electrode and holmium laser, as well as the assessment of associated tissue mass and volume loss of benign prostatic hyperplasia (BPH).
MATERIAL AND METHODS: The material used in this study consisted of 74 preparations of prostatic adenoma obtained via open retropubic adenomectomy, with an average volume of 120.7 ml. The material obtained cut in vitro before fixation in formaldehyde. One lobe was cut using holmium laser, the other using a monopolar cutting electrode. After the incision was made, tissue mass and volume loss were evaluated. Thermocoagulation changes in the incision line were examinedunder light microscope.
RESULTS: In the case of the holmium laser incision, the average tissue mass loss was 1.73 g, tissue volume loss 3.57 ml and the depth of thermocoagulation was 1.17 mm. When the monopolar cutting electrode was used average tissue mass loss was 0.807 g, tissue volume loss 2.48 ml and the depth of thermocoagulation was 0.19 mm.
CONCLUSIONS: Where holmium laser was used, it was observed that the layer of tissue with thermocoagulation changes was deeper than in the case of the monopolar cutting electrode. Moreover, it was noticed that holmium laser caused bigger tissue mass and volume loss than the cutting electrode.
Keywords: BPH; TURP; holmium laser; mass loss; prostate
References
- Eur Urol. 2011 Oct;60(4):734-9 - PubMed
- Cent European J Urol. 2011;64(1):26-9 - PubMed
- Eur Urol. 2006 Nov;50(5):969-79; discussion 980 - PubMed
- J Urol. 1989 Feb;141(2):243-7 - PubMed
- Scand J Urol Nephrol. 2003;37(6):494-7 - PubMed
- J Urol. 2005 Sep;174(3):998-1001; discussion 1001 - PubMed
- J Endourol. 2003 Oct;17(8):595-600 - PubMed
- BJU Int. 2007 Jul;100(1):94-101 - PubMed
- Urology. 2005 Nov;66(5 Suppl):108-13 - PubMed
- J Urol. 2006 Apr;175(4):1428-32 - PubMed
- BJU Int. 2005 Oct;96(5):736-9 - PubMed
- BJU Int. 1999 Jul;84(1):1-9 - PubMed
- J Urol. 1990 Mar;143(3):533-7 - PubMed
- Urology. 1998 Apr;51(4):573-7 - PubMed
- Eur Urol. 2008 Feb;53(2):382-89 - PubMed
- Eur Urol. 2007 Nov;52(5):1465-71 - PubMed
- Eur Urol. 2013 May;63(5):859-67 - PubMed
- Eur Urol. 2006 Sep;50(3):563-8 - PubMed
- Eur Urol. 2008 Jan;53(1):160-6 - PubMed
- J Endourol. 2000 Jun;14(5):459-62 - PubMed
- Br J Urol. 1998 May;81(5):712-20 - PubMed
- J Endourol. 1998 Oct;12(5):457-9 - PubMed
- Eur Urol. 2005 Dec;48(6):965-71; discussion 972 - PubMed
- Asian J Androl. 2009 May;11(3):277-81 - PubMed
- J Urol. 2004 Aug;172(2):616-9 - PubMed
- Int J Urol. 2004 Nov;11(11):978-82 - PubMed
- Eur Urol. 2006 Jun;49(6):961-9 - PubMed
- Urology. 2005 Oct;66(4):789-93 - PubMed
Publication Types